Defective B cell development and function in Btk-deficient mice
- PMID: 7552994
- DOI: 10.1016/1074-7613(95)90114-0
Defective B cell development and function in Btk-deficient mice
Abstract
Mutations in the Bruton's tyrosine kinase (Btk) gene have been linked to severe early B cell developmental blocks in human X-linked agammaglobulinemia (XLA), and to milder B cell activation deficiencies in murine X-linked immune deficiency (Xid). To elucidate unequivocally potential Btk functions in mice, we generated mutations in embryonic stem cells, which eliminated the ability to encode Btk pleckstrin homology or kinase domains, and assayed their effects by RAG2-deficient blastocyst complementation or introduction into the germline. Both mutations block expression of Btk protein and lead to reduced numbers of mature conventional B cells, severe B1 cell deficiency, serum IgM and IgG3 deficiency, and defective responses in vitro to various B cell activators and in vivo to immunization with thymus-independent type II antigens. These results prove that lack of Btk function results in an Xid phenotype and further suggest a differential requirement for Btk during the early stages of murine versus human B lymphocyte development.
Similar articles
-
Impaired expansion of mouse B cell progenitors lacking Btk.Immunity. 1995 Sep;3(3):301-12. doi: 10.1016/1074-7613(95)90115-9. Immunity. 1995. PMID: 7552995
-
Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.J Immunol. 2002 Jun 1;168(11):5465-76. doi: 10.4049/jimmunol.168.11.5465. J Immunol. 2002. PMID: 12023340
-
An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10966-71. doi: 10.1073/pnas.93.20.10966. Proc Natl Acad Sci U S A. 1996. PMID: 8855292 Free PMC article.
-
Role of Bruton's tyrosine kinase in B cell development.Dev Immunol. 2001;8(3-4):171-81. doi: 10.1155/2001/28962. Dev Immunol. 2001. PMID: 11785667 Free PMC article. Review.
-
Signalling of Bruton's tyrosine kinase, Btk.Scand J Immunol. 1999 Feb;49(2):113-8. doi: 10.1046/j.1365-3083.1999.00504.x. Scand J Immunol. 1999. PMID: 10075013 Review.
Cited by
-
Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies.Cancers (Basel). 2024 Oct 10;16(20):3434. doi: 10.3390/cancers16203434. Cancers (Basel). 2024. PMID: 39456530 Free PMC article. Review.
-
Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor.Nat Commun. 2015 Feb 3;6:6168. doi: 10.1038/ncomms7168. Nat Commun. 2015. PMID: 25644899 Free PMC article.
-
Central role for marginal zone B cells in an animal model of Sjogren's syndrome.Clin Immunol. 2016 Jul;168:30-36. doi: 10.1016/j.clim.2016.04.008. Epub 2016 Apr 30. Clin Immunol. 2016. PMID: 27140729 Free PMC article.
-
Heterozygous mis-sense mutations in Prkcb as a critical determinant of anti-polysaccharide antibody formation.Genes Immun. 2013 Jun;14(4):223-33. doi: 10.1038/gene.2013.11. Epub 2013 Apr 4. Genes Immun. 2013. PMID: 23552399 Free PMC article.
-
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19. N Engl J Med. 2013. PMID: 23782158 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases